scispace - formally typeset
Open AccessJournal ArticleDOI

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.

Reads0
Chats0
TLDR
In this article, the authors describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.
About
This article is published in The Lancet.The article was published on 2021-01-16 and is currently open access. It has received 2933 citations till now. The article focuses on the topics: Pulmonary diffusion & Severity of illness.

read more

Citations
More filters
Journal ArticleDOI

One-year mortality and consequences of COVID-19 in cancer patients: A cohort study.

TL;DR: In this article, the 1-year mortality and health consequences of COVID-19 in cancer patients are relatively underexplored, and a multicenter cohort study was conducted to compare COVID19 patients with cancer patients and non-COVID cancer patients.
Journal ArticleDOI

Impact of the COVID-19 pandemic on the care of cancer patients in Spain.

TL;DR: In this paper, the authors evaluated the impact of the COVID-19 pandemic on cancer patients in Spanish hospitals during the first wave of the pandemic by collecting information from hospital departments treating oncology patients.
Journal ArticleDOI

‘Trapped’, ‘anxious’ and ‘traumatised’: COVID-19 intensified the impact of housing inequality on Australians’ mental health

TL;DR: In this article, increased time spent at home during COVID-19 exposed inequities in Australian housing quality and availability, and many Australians lack sufficient space to carry out activities shifted to their homes.
References
More filters
Journal ArticleDOI

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

TL;DR: A 5-level version of the EQ-5D has been developed by the EuroQol Group and further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Journal ArticleDOI

Dexamethasone in Hospitalized Patients with Covid-19

TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
Related Papers (5)
Trending Questions (1)
What is the implications of reshoring after covid?

The given text does not provide any information about the implications of reshoring after COVID-19.